Jump to content
RemedySpot.com

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes

Rate this topic


Guest guest

Recommended Posts

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and

PSI-938 for All HCV Genotypes

From the PharmaLive.com News Archive - Sep. 13, 2011

Pharmasset, Inc. announced today that screening has begun in a Phase 2b,

international study of PSI-7977 and PSI-938, two nucleotide analog polymerase

inhibitors for the treatment of chronic hepatitis C (HCV).

Link to comment
Share on other sites

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and

PSI-938 for All HCV Genotypes

From the PharmaLive.com News Archive - Sep. 13, 2011

Pharmasset, Inc. announced today that screening has begun in a Phase 2b,

international study of PSI-7977 and PSI-938, two nucleotide analog polymerase

inhibitors for the treatment of chronic hepatitis C (HCV).

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...